Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies

investors.com/news/technology/intellia-therapeutics-stock-gene-editing-patient-dies

Intellia Therapeutics stock crashed Friday after a patient in its gene-editing study died following serious increases in liver enzymes.
The post Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-11-07 13:45:42.
The Entire Business World on a Single Page. Free to Use →